Advances in cell transplantation combined with other therapeutic strategies in the treatment for vitiligo

doi:10.16352/j.issn.1001-6325.2024.11.1584

Abstract

Abstract: Vitiligo is an acquired depigmentation skin disease characterized by a decrease or loss of function of melanocytes.The conventional treatment for vitiligo include drug therapy, phototherapy and surgical treatment. As an important surgical treatment for vitiligo, cell transplantation is effective especially for the case which is stable, limited or fail to respond to other methods,but the recoloration rate varies greatly. The combination therapy is a better choice to maximize the recoloration of skin lesions in patients with refractory vitiligo. In recent years, reports on the combined strategy of cell transplantation have gradually increased, bringing new hope to improve the rate of discoloration of vitiligo patients. This paper reviews the progress of the application of cell transplantation combination strategy aiming for providing more options for the clinical treatment of refractory vitiligo.

Key words: vitiligo, cell transplantation, combination therapies, celanocyte

CLC Number:

R758.41

LIU Shangkun, WANG Hongjuan, KANG Xiaojing. Advances in cell transplantation combined with other therapeutic strategies in the treatment for vitiligo[J]. Basic & Clinical Medicine, 2024, 44(11): 1584-1588.

References

[1] Bergqvist C, Ezzedine K. Vitiligo: a review[J]. Dermatology, 2020, 236: 571-592.
[2] Liu B, Chen HH, Liu ZH, et al. The clinical efficacy of treatment using the autologous non-cultured epidermal cell suspension technique for stable vitiligo in 41 patients[J]. Dermatolog Treat, 2021, 32: 90-94.
[3] Zhu MC, Ma HY, Zhan Z, et al. Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo[J]. Exp Ther Med,2017, 13: 23-28.
[4] Zhang D, Wei X, Hong W, et al. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation[J]. Aging (Albany NY), 2021, 13: 5415-5425.
[5] Shi HX, Zhang RZ, Xu B, et al. Experimental study and clinical observations of autologous hair follicle cell transplants to treat stable vitiligo[J]. Indian J Dermatol Venereol Leprol,2020, 86: 124-133.
[6] Thakur V, Kumar S, Kumaran MS, et al. Efficacy of transplantation of combination of noncultured dermal and epidermal cell suspension vs epidermal cell suspension alone in vitiligo: a randomized clinical trial[J]. JAMA Dermatol, 2019, 155: 204-210.
[7] Razmi M, Kumar R, Rani S, et al. Combination of follicular and epidermal cell suspension as a novel surgical approach in difficult-to-treat vitiligo: a randomized clinical trial[J]. JAMA Dermatol, 2018, 154: 301-308.
[8] Verma R, Grewal RS, Chatterjee M, et al. A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo[J]. Med J Armed Forces India, 2014, 70: 26-31.
[9] Shi HX, Zhang RZ, Xiao L, et al. Effects of keratinocyte-derived and fibroblast-derived exosomes on human epidermal melanocytes[J]. Indian J Dermatol Venereol Leprol, 2022, 88: 322-331.
[10] Takano K, Hachiya A, Murase D, et al. Quantitative changes in the secretion of exosomes from keratinocytes homeostatically regulate skin pigmentation in a paracrine manner[J]. J Dermatol, 2020, 47: 265-276.
[11] Zhang C, Zhou L, Huang J, et al. A preliminary study of growth characteristics of melanocytes co-cultured with keratinocytes in vitro[J]. J Cell Biochem, 2018, 119: 6173-6180.
[12] Zhu L, Lin X, Zhi L, et al. Mesenchymal stem cells promote human melanocytes proliferation and resistance to apoptosis through PTEN pathway in vitiligo[J].Stem Cell Res Ther, 2020, 11: 1-14.
[13] Kim H, Yi N, Do BR, et al. Adipose-derived stem cell coculturing stimulates integrin-mediated extracellular matrix adhesion of melanocytes by upregulating growth factors[J]. Biomol Ther (Seoul), 2019, 27: 185-192.
[14] Lommerts JE, Uitentuis SE, Bekkenk MW, et al. The role of phototherapy in the surgical treatment of vitiligo: a systematic review[J]. J Eur Acad Dermatol Venereol, 2018, 32: 1427-1435.
[15] Zhang D, Hong W, Fu L, et al. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo[J]. Dermatol Surg, 2014, 40: 420-426.
[16] Tawfik YM, Abd Elazim NE, Abdel-Motaleb AA, et al. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios[J]. J Cosmet Dermatol, 2019, 18: 638-646.
[17] Zhang B, Li T, Tang Y, et al. The effects of 308-nm excimer laser on the infiltration of CD4⁺, CD8⁺ T-cells, and regulatory T cells in the lesional skin of patients at active and stable stages of nonsegmental vitiligo[J].J Dermatolog Treat, 2021, 32: 580-584.
[18] Chang HC, Sung CW. Efficacy of combination therapy of narrowband-ultraviolet B phototherapy or excimer laser with topical tacrolimus for vitiligo: an updated systematic review and Meta-analysis[J]. Photodermatol Photoimmunol Photomed, 2021, 37: 74-77.
[19] Ebadi A, Rad MM, Nazari S, et al. The additive effect of excimer laser on non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population[J]. J Eur Acad Dermatol Venereol, 2015, 29: 745-751.
[20] Zahra FT, Adil M, Amin SS, et al. Efficacy of topical 5% 5-fluorouracil with needling versus 5% 5-fluorouracil alone in stable vitiligo: a randomized controlled study[J].J Cutan Aesthet Surg, 2020, 13: 197.doi:10.4103/JCAS.JCAS-12_20.
[21] Attwa EM, Khashaba SA, Ezzat NA. Evaluation of the additional effect of topical 5-fluorouracil to needling in the treatment of localized vitiligo[J]. J Cosmet Dermatol, 2020, 19: 1473-1478.
[22] Albalat W, Elsayed M, Salem A, et al. Microneedling and 5-flurouracil can enhance the efficacy of non-cultured epidermal cell suspension transplantation for resistant acral vitiligo[J]. Dermatol Ther, 2022, 35: e15768.doi:10.1111/dth.15768.
[23] Mutalik S, Shah S, Sidwadkar V, et al. Efficacy of cyclosporine after autologous noncultured melanocyte transplantation in localized stable vitiligo-a pilot, open label, comparative study[J]. Dermatol Surg, 2017, 43: 1339-1347.
[24] Rekik M, Mseddi M, Kammoun N, et al. Efficacy of autologous platelet-rich plasma in the treatment of vitiligo: a 10-patient prospective study[J]. J Cosmet Dermatol, 2022, 21: 4225-4233.
[25] Albalat W, Elsayed M, Salem A, et al. Non-cultured epidermal cells suspended in either platelet-rich plasma or ringer lactate for stable vitiligo: a prospective comparative study[J]. J Cosmet Dermatol, 2022, 21: 3102-3109.